Gregory Nathan Fancher, MS | |
603 Barnwell Hwy, Allendale, SC 29810-1905 | |
(803) 584-4636 | |
(803) 584-5065 |
Full Name | Gregory Nathan Fancher |
---|---|
Gender | Male |
Speciality | Psychologist - Cognitive & Behavioral |
Location | 603 Barnwell Hwy, Allendale, South Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578623914 | NPI | - | NPPES |
421504 | Medicaid | SC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TB0200X | Psychologist - Cognitive & Behavioral | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Gregory Nathan Fancher, MS 1050 Ribaut Rd, Beaufort, SC 29902-5400 Ph: (843) 524-8899 | Gregory Nathan Fancher, MS 603 Barnwell Hwy, Allendale, SC 29810-1905 Ph: (803) 584-4636 |
News Archive
An overwhelming majority of gay and lesbian people in New Zealand want government recognition of same sex relationships. Most of them would prefer that recognition to be marriage rather than a civil union. That is one of the many findings from the Lavender Islands survey – the most extensive survey of this community ever undertaken in New Zealand.
As Medicare is put under the microscope in the debt-ceiling talks, the clock is running out for Centers for Medicare and Medicaid Services Administrator Donald Berwick to be confirmed by Congress.
Daiichi Sankyo, Company Limited (hereafter, Daiichi Sankyo) today announced that the Marketing Authorization Application for its investigational, oral, once-daily direct factor Xa-inhibitor edoxaban has been submitted to the European Medicines Agency.
Synthetic Biologics, Inc.), a clinical stage company focused on developing therapeutics to protect the gut microbiome while targeting pathogen specific diseases, announced positive topline results from the first Phase 2a study of SYN-004, the Company's candidate designed to protect the gut microbiome from the unintended effects of certain commonly used intravenous (IV) beta-lactam antibiotics for the prevention C. difficile infection (CDI) and antibiotic-associated diarrhea (AAD).
› Verified 4 days ago